Publications by authors named "Alessandra Alessi"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

14,510

Total Likes

411

Extended Reach

26,624

Social Features

9
E
Exceptional tumour responses to fasting-mimicking diet combined with standard anticancer therapies: A sub-analysis of the NCT03340935 trial.
Francesca Ligorio, Giovanni Fucà, Leonardo Provenzano, Riccardo Lobefaro, Lucrezia Zanenga, Andrea Vingiani, Antonino Belfiore, Alice Lorenzoni, Alessandra Alessi, Giancarlo Pruneri

September 2022

Videos about Article: user user

2 7 3

View All Article and Social Media Activity
R
Radioembolization of hepatocellular carcinoma with Y glass microspheres: an earlier administration day unexpectedly improves tumour control probability.
Matteo Bagnalasta, Stefania Mazzaglia, Maria Chiara De Nile, Chiara Romanò, Giovanna Pitoni, Alessandra Alessi

Eur J Nucl Med Mol Imaging· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COL1A1::PDGFB fusion-associated uterine fibrosarcoma: A case report and review of the literature.
Simone Rota, Andrea Franza, Chiara Fabbroni, Biagio Paolini, Francesca Gabriella Greco, Alessandra Alessi

Cancer Rep (Hoboken)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Baseline [F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study.
Andrea Bianchi, Maria Luisa De Rimini, Rosa Sciuto, Alessio Annovazzi, Silvia Di Traglia, Alessandra Alessi

Cancer Biother Radiopharm· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and External Validation of a PET Radiomic Model for Prognostication of Head and Neck Cancer.
Wyanne A Noortman, Nicolas Aide, Dennis Vriens, Lisa S Arkes, Cornelis H Slump, Alessandra Alessi

Cancers (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Deauville score and quantitative positron emission tomography parameters as a predictive tool of anti-CD19 chimeric antigen receptor T-cell efficacy.
Anna Guidetti, Anna Dodero, Alice Lorenzoni, Sara Pizzamiglio, Giovanni Argiroffi, Alessandra Alessi

Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors.
Laura Evangelista, Andrea Bianchi, Alessio Annovazzi, Rosa Sciuto, Silvia Di Traglia, Alessandra Alessi

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy.
Laura Marandino, Antonella Capozza, Marco Bandini, Daniele Raggi, Elena Farè, Alessandra Alessi

Eur Urol Focus· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Role of Early Interim Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced Seminoma Undergoing Standard Treatment.
Daniele Raggi, Marco Bandini, Patrizia Giannatempo, Elena Farè, Laura Marandino, Alessandra Alessi

Clin Genitourin Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab.
Laura Marandino, Antonella Capozza, Marco Bandini, Daniele Raggi, Elena Farè, Alessandra Alessi

Urol Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CT, [F]FDG-PET/CT and clinical findings before and during early Covid-19 onset in a patient affected by vascular tumour.
Margarita Kirienko, Barbara Padovano, Gianluca Serafini, Alfonso Marchianò, Alessandro Gronchi, Alessandra Alessi

Eur J Nucl Med Mol Imaging· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methodological framework for radiomics applications in Hodgkin's lymphoma.
Martina Sollini, Margarita Kirienko, Lara Cavinato, Francesca Ricci, Matteo Biroli, Alessandra Alessi

Eur J Hybrid Imaging· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapy.
Alessandra Alessi, Alice Lorenzoni, Anna Cavallo, Barbara Padovano, Nicola Alessandro Iacovelli

Radiol Med· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients With Potentially Resectable Colorectal Cancer Liver Metastases.
Filippo Pietrantonio, Christian Cotsoglou, Giovanni Fucà, Salvatore Lo Vullo, Federico Nichetti, Alessandra Alessi, Alessia Mennitto

Clin Colorectal Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME).
Martina Imbimbo, Margaret Ottaviano, Milena Vitali, Alessandra Fabbri, Giovanni Leuzzi, Alessandra Alessi

Cancer Treat Rev· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Metastatic Collecting Duct Carcinoma: An Encouraging Result in a Patient Treated With Cabozantinib.
Alessia Mennitto, Elena Verzoni, Giorgia Peverelli, Alessandra Alessi, Giuseppe Procopio

Clin Genitourin Cancer· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exceptional response to olaparib in BRCA2-altered urothelial carcinoma after PD-L1 inhibitor and chemotherapy failure.
Andrea Necchi, Daniele Raggi, Patrizia Giannatempo, Alessandra Alessi, Gianluca Serafini

Eur J Cancer· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions.
Rosa Berenato, Federica Morano, Filippo Pietrantonio, Christian Cotsoglou, Marta Caporale, Alessandra Alessi, Alessia Mennitto

Oncology· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative Triplet Chemotherapy and Cetuximab in Patients With RAS Wild Type High Recurrence Risk or Borderline Resectable Colorectal Cancer Liver Metastases.
Filippo Pietrantonio, Maria Di Bartolomeo, Christian Cotsoglou, Alessia Mennitto, Rosa Berenato, Alessandra Alessi

Clin Colorectal Cancer· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF-Mutated Colorectal Cancer.
Filippo Pietrantonio, Daniele Oddo, Annunziata Gloghini, Emanuele Valtorta, Rosa Berenato, Alessandra Alessi

Cancer Discov· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDG-PET/CT to predict optimal primary cytoreductive surgery in patients with advanced ovarian cancer: preliminary results.
Alessandra Alessi, Fabio Martinelli, Barbara Padovano, Gianluca Serafini, Domenica Lorusso

Tumori· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interim (18)F-Fluorodeoxyglucose Positron Emission Tomography for Early Metabolic Assessment of Response to Cisplatin, Etoposide, and Bleomycin Chemotherapy for Metastatic Seminoma: Clinical Value and Future Directions.
Andrea Necchi, Nicola Nicolai, Alessandra Alessi, Rosalba Miceli, Patrizia Giannatempo

Clin Genitourin Cancer· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
¹⁸F-FLT PET/CT as an imaging tool for early prediction of pathological response in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy: a pilot study.
Flavio Crippa, Roberto Agresti, Marco Sandri, Gabriella Mariani, Barbara Padovano, Alessandra Alessi

Eur J Nucl Med Mol Imaging· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interim fluorine-18 fluorodeoxyglucose positron emission tomography for early metabolic assessment of therapeutic response to chemotherapy for metastatic transitional cell carcinoma.
Patrizia Giannatempo, Alessandra Alessi, Rosalba Miceli, Daniele Raggi, Elena Farè

Clin Genitourin Cancer· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum thymus and activation-regulated chemokine level monitoring may predict disease relapse detected by PET scan after reduced-intensity allogeneic stem cell transplantation in patients with Hodgkin lymphoma.
Lucia Farina, Francesca Rezzonico, Francesco Spina, Anna Dodero, Arabella Mazzocchi, Alessandra Alessi

Biol Blood Marrow Transplant· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis